|
Volumn 10, Issue 11, 2006, Pages 1185-1187
|
XDR-TB: Entering the post-antibiotic era?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIKACIN;
AMINOGLYCOSIDE;
ANTIBIOTIC AGENT;
CYCLOSERINE;
ETHAMBUTOL;
ETHIONAMIDE;
ISONIAZID;
KANAMYCIN;
PYRAZINAMIDE;
QUINOLONE DERIVATIVE;
RIFAMPICIN;
STREPTOMYCIN;
TUBERCULOSTATIC AGENT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
DISEASE CONTROL;
DRUG SENSITIVITY;
EDITORIAL;
HOSPITALIZATION;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION CONTROL;
INFECTION PREVENTION;
INFECTION RISK;
MULTIDRUG RESISTANCE;
PREVALENCE;
PRIORITY JOURNAL;
PROPHYLAXIS;
TUBERCULOSIS;
UNITED STATES;
WORLD HEALTH ORGANIZATION;
ANTIBIOTICS, ANTITUBERCULAR;
DISEASE OUTBREAKS;
HUMANS;
MYCOBACTERIUM TUBERCULOSIS;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
WORLD HEALTH;
|
EID: 33750811319
PISSN: 10273719
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (99)
|
References (6)
|